Amgen To Present At The 2020 Bank of America Virtual Global Healthcare Conference

Amgen (NASDAQ:AMGN) will present at the Bank of America Virtual Global Healthcare Conference at 12:35 p.m. ET on Sept. 17, 2020.

Rhea-AI Summary

Amgen (NASDAQ:AMGN) will present at the Bank of America Virtual Global Healthcare Conference at 12:35 p.m. ET on Sept. 17, 2020. The presentation will be made by Peter H. Griffith, executive vice president and CFO of Amgen. Interested parties can access the live audio on Amgen's website under the Events Calendar, with replays available for 90 days following the event. Amgen is dedicated to innovative therapeutics to improve health outcomes and has a strong pipeline of medicines aimed at serious illnesses.

Argus Session date unavailable

+0.65% session move Open Argus

Details

News Market Reaction – AMGN

The recorded move for AMGN in the trading session of this news was +0.65%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

THOUSAND OAKS, Calif., Sept. 14, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Bank of America Virtual Global Healthcare Conference at 12:35 p.m. ET on Thursday, Sept. 17, 2020. Peter H. Griffith, executive vice president and chief financial officer at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors. A replay of the webcast will also be available on Amgen's website for at least 90 days following the event.

About Amgen 
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.  

CONTACT: Amgen, Thousand Oaks 
Megan Fox, 805-447-1423 (media)
Trish Rowland, 805-447-5631 (media) 
Arvind Sood, 805-447-1060 (investors) 

 

View original content:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-2020-bank-of-america-virtual-global-healthcare-conference-301130346.html

SOURCE Amgen

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Amgen present at the Bank of America Virtual Global Healthcare Conference?

Amgen will present at the conference on Sept. 17, 2020, at 12:35 p.m. ET.

Who is presenting Amgen's conference session?

The session will be presented by Peter H. Griffith, executive vice president and CFO of Amgen.

Where can I listen to Amgen's presentation live?

The live audio of Amgen's presentation can be accessed on their website under the Events Calendar.

Will there be a replay of Amgen's presentation?

Yes, a replay of the webcast will be available on Amgen's website for at least 90 days after the event.

What is Amgen's focus in biopharmaceuticals?

Amgen is focused on discovering and delivering innovative therapeutics for serious illnesses, utilizing advanced human genetics.